Free Trial
NASDAQ:GDRX

GoodRx Q3 2026 Earnings Date & Estimates

GoodRx logo
$3.51 0.00 (0.00%)
Closing price 11/6/2026 04:00 PM Eastern
Extended Trading
$3.68 +0.17 (+4.73%)
As of 06:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GoodRx is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes

What Analysts Expect from GoodRx in Q3 2026

GoodRx is expected to post earnings of $0.0779 per share on revenue of $202.07 million. In the same quarter a year earlier GoodRx reported $0.08 per share on revenue of $196.03 million. GoodRx last reported on August 5, 2026, posting $0.08 per share and beating the $0.0797 consensus estimate. GoodRx has beaten the consensus EPS estimate in 2 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.0779
Expected Revenue
$202.07 million
Prior-Year EPS
$0.08
Prior-Year Revenue
$196.03 million
Expected EPS Growth
-2.7%
Expected Revenue Growth
+3.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.08 (Beat by +$0.0003)
Last Quarter Revenue
$200.41 million
EPS Beat Rate
2 of last 8 quarters

GoodRx Q3 2026 Earnings FAQ

GoodRx (NASDAQ:GDRX) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

GoodRx's Q3 2026 earnings conference call is scheduled for Wednesday, November 18, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect GoodRx to post earnings of $0.0779 per share for Q3 2026.

The consensus revenue estimate for GoodRx is $202.07 million for Q3 2026.

GoodRx Earnings Headlines

3 Penny Stocks With Revenue Growth Up To 44%
GoodRx (GDRX) Projected to Release Quarterly Earnings on Tuesday
One Ticker Tied to a Coming 401k Change
An email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will delete it without a second look. Larry Benedict says that would be a mistake. He calls this the decade's biggest opportunity and is naming the one ticker to watch before it arrives. Watch his free breakdown now.tc pixel
GoodRx Announces Launch Of Employer Direct Weight Loss Offering
GoodRx Launches Employer Direct Weight Loss Offering
See More GoodRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GoodRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your email.

About GoodRx

GoodRx (NASDAQ:GDRX) operates a digital healthcare platform that helps consumers find and access lower prices for prescription medications. Through its website and mobile applications, GoodRx allows users to compare prices at participating pharmacies, obtain prescription discount coupons and identify potential savings on commonly prescribed drugs. The company’s services are generally available at pharmacies across the United States.

GoodRx also offers GoodRx Gold, a membership program that provides additional discounts on eligible prescriptions, as well as healthcare-related content and tools designed to help consumers understand medications and treatment options. Its platform connects consumers with pharmacies, healthcare providers and pharmaceutical companies, supporting prescription savings, medication information and other consumer healthcare services.

The company was founded in 2011 by Trevor Bezdek, Doug Hirsch and Scott Marlette. GoodRx became a publicly traded company on the Nasdaq under the symbol GDRX in 2020. Its business is primarily focused on the U.S. healthcare market and is intended to complement, rather than replace, traditional health insurance by helping consumers compare out-of-pocket prescription costs.

View GoodRx Profile